Classic activating mutations of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) are found in approximately 47% of patients in Asian-Pacific countries (2). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.